**7. References**


<sup>\*</sup> Corresponding Author

[13] Parthasarathy, S., D. Steinberg, and J.L. Witztum, *The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.* Annu Rev Med, 1992. 43: p. 219-25.

244 Lipoproteins – Role in Health and Diseases

**Author details** 

**7. References** 

105(9): p. 1135-43.

71(3): p. 380-6.

101(13): p. 1500-2.

Corresponding Author

 \*

Xiaoyan Zhang and Hainsworth Y. Shin\*

neutrophil mechanotransduction and to determine if chronic inflammation precedes or results from an impairment of vascular mechanotransduction. Further work is, therefore, needed to determine mechanistic-level connections between the cell surface, the flow sensors, the extracellular flow environment, and the influence of a hypercholesterolemic environment on these. The hope is that by fully defining the role of fluid mechanics in the physiological regulation of leukocytes, particularly the neutrophils, one may gain a better

[1] Mazzoni, M.C. and G.W. Schmid-Schönbein, *Mechanisms and consequences of cell* 

[4] Libby, P., P.M. Ridker, and A. Maseri, *Inflammation and atherosclerosis.* Circulation, 2002.

[5] Steinberg, D., *Atherogenesis in perspective: hypercholesterolemia and inflammation as partners* 

[6] Boullier, A., et al., *Scavenger receptors, oxidized LDL, and atherosclerosis.* Ann N Y Acad

[7] Stokes, K.Y., et al., *Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide.* Free Radic Biol Med, 2002. 33(8): p. 1026-36. [8] Scalia, R., J.Z. Appel, 3rd, and A.M. Lefer, *Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1.*

[9] Stokes, K.Y., et al., *NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-*

[10] Mori, N., et al., *Ischemia-reperfusion induced microvascular responses in LDL-receptor -/-* 

[11] Lehr, H.A., et al., *P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo.* Lab Invest, 1994.

[12] Vink, H., A.A. Constantinescu, and J.A. Spaan, *Oxidized lipoproteins degrade the endothelial surface layer : implications for platelet-endothelial cell adhesion.* Circulation, 2000.

*induced leukocyte-endothelial cell adhesion.* Circ Res, 2001. 88(5): p. 499-505.

understanding of their role in the pathogenesis of cardiovascular disease.

*Center for Biomedical Engineering, University of Kentucky, Lexington, KY, USA* 

*activation in the microcirculation.* Cardiovasc Res, 1996. 32(4): p. 709-19. [2] Gorman C, P.K.D.A., and Cray D, *The Fires Within.* Time, 2004. 163: p. 30-46.

[3] Underwood, A., *Quieting a Body's Defenses.* Newsweek, 2005.

Arterioscler Thromb Vasc Biol, 1998. 18(7): p. 1093-100.

*mice.* Am J Physiol, 1999. 276(5 Pt 2): p. H1647-54.

*in crime.* Nat Med, 2002. 8(11): p. 1211-7.

Sci, 2001. 947: p. 214-22; discussion 222-3.


[48] Phillips, M.C., W.J. Johnson, and G.H. Rothblat, *Mechanisms and consequences of cellular cholesterol exchange and transfer.* Biochim Biophys Acta, 1987. 906(2): p. 223-76.

246 Lipoproteins – Role in Health and Diseases

1997. 186(5): p. 739-47.

131.

p. 5-15.

Blood, 2008. 112(4): p. 1461-71.

Microvasc Res, 1996. 51(2): p. 187-201.

Biochem, 1997. 34 ( Pt 3): p. 269-75.

Acad Sci U S A, 1976. 73(9): p. 3178-82.

Arterioscler Thromb Vasc Biol, 2009. 29(9): p. 1290-7.

*atherosclerosis.* Annu Rev Biochem, 1977. 46: p. 897-930.

2011. 301(2): p. C451-60.

*capillaries.* Science, 1989. 245(4914): p. 183-6.

[31] Chertov, O., et al., *Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils.* J Exp Med,

[32] Soehnlein, O., et al., *Neutrophil secretion products pave the way for inflammatory monocytes.*

[33] Schmid-Schönbein, G.W., *Analysis of inflammation.* Annu Rev Biomed Eng, 2006. 8: p. 93-

[34] Eppihimer, M.J. and H.H. Lipowsky, *Effects of leukocyte-capillary plugging on the resistance to flow in the microvasculature of cremaster muscle for normal and activated leukocytes.*

[35] Worthen, G.S., et al., *Mechanics of stimulated neutrophils: cell stiffening induces retention in* 

[36] Helmke, B.P., et al., *A mechanism for erythrocyte-mediated elevation of apparent viscosity by leukocytes in vivo without adhesion to the endothelium.* Biorheology, 1998. 35(6): p. 437-48. [37] Lipowsky, H.H., *Microvascular rheology and hemodynamics.* Microcirculation, 2005. 12(1):

[38] Lange, Y., et al., *Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts.* J Biol Chem, 1989. 264(7): p. 3786-93. [39] Day, A.P., et al., *Effect of simvastatin therapy on cell membrane cholesterol content and membrane function as assessed by polymorphonuclear cell NADPH oxidase activity.* Ann Clin

[40] Zhang, X., et al., *Membrane cholesterol modulates the fluid shear stress response of polymorphonuclear leukocytes via its effects on membrane fluidity.* Am J Physiol Cell Physiol,

[41] Oh, H., et al., *Membrane cholesterol is a biomechanical regulator of neutrophil adhesion.*

[42] Cooper, R.A., *Influence of increased membrane cholesterol on membrane fluidity and cell* 

[43] Goldstein, J.L. and M.S. Brown, *The low-density lipoprotein pathway and its relation to* 

[44] Brasaemle, D.L. and A.D. Attie, *Rapid intracellular transport of LDL-derived cholesterol to* 

[45] Lara, L.L., et al., *Low density lipoprotein receptor expression and function in human* 

[46] Goldstein, J.L. and M.S. Brown, *Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with* 

*function in human red blood cells.* J Supramol Struct, 1978. 8(4): p. 413-30.

*the plasma membrane in cultured fibroblasts.* J Lipid Res, 1990. 31(1): p. 103-12.

*homozygous familial hypercholesterolemia.* J Biol Chem, 1974. 249(16): p. 5153-62. [47] Basu, S.K., et al., *Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.* Proc Natl

*polymorphonuclear leucocytes.* Clin Exp Immunol, 1997. 107(1): p. 205-12.


[85] Shive, M.S., W.G. Brodbeck, and J.M. Anderson, *Activation of caspase 3 during shear stressinduced neutrophil apoptosis on biomaterials.* J Biomed Mater Res, 2002. 62(2): p. 163-8.

248 Lipoproteins – Role in Health and Diseases

J Pathol, 1995. 146(1): p. 218-27.

Chim Acta, 1984. 144(1): p. 11-6.

Atherosclerosis, 1995. 117(1): p. 61-71.

p. 1775-90.

25(6): p. 1262-7.

48(1): p. 49-64.

Pt 1): p. 921-8.

44(4): p. 221-49.

94(10): p. 5338-43.

Raton, FL, USA. p. 139-75.

*leukocytes.* Circ Res, 2000. 86(1): p. E13-8.

[68] Tuluc, F., J. Meshki, and S.P. Kunapuli, *Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils.* Int Immunopharmacol, 2003. 3(13-14):

[69] Stulc, T., et al., *Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment.* Physiol Res, 2008. 57(2): p. 184-94. [70] Lehr, H.A., et al., *In vitro effects of oxidized low density lipoprotein on CD11b/CD18 and Lselectin presentation on neutrophils and monocytes with relevance for the in vivo situation.* Am

[71] Sugano, R., et al., *Polymorphonuclear leukocytes may impair endothelial function: results of crossover randomized study of lipid-lowering therapies.* Arterioscler Thromb Vasc Biol, 2005.

[72] Furlow, M. and S.L. Diamond, *Interplay between membrane cholesterol and ethanol differentially regulates neutrophil tether mechanics and rolling dynamics.* Biorheology, 2011.

[73] Tailor, A. and D.N. Granger, *Hypercholesterolemia promotes leukocyte-dependent platelet adhesion in murine postcapillary venules.* Microcirculation, 2004. 11(7): p. 597-603. [74] Lechi, C., et al., *Increased leukocyte aggregation in patients with hypercholesterolaemia.* Clin

[75] Araujo, F.B., et al., *Evaluation of oxidative stress in patients with hyperlipidemia.*

[76] Kristal, B., et al., *Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension.* Am J Hypertens, 1998. 11(8

[77] Shurtz-Swirski, R., et al., *Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients.* Diabetes Care, 2001. 24(1): p. 104-10. [78] Makino, A., et al., *Mechanotransduction in leukocyte activation: a review.* Biorheology, 2007.

[79] Shin, H.Y., et al., *Mechanobiological Evidence for the Control of Neutrophil Activity by Fluid Shear Stress* in *Mechanobiology Handbook*, J. Nagatomi, Editor 2011, CRC Press: Boca

[80] Fukuda, S. and G.W. Schmid-Schönbein, *Centrifugation attenuates the fluid shear response* 

[81] Fukuda, S., et al., *Mechanisms for regulation of fluid shear stress response in circulating* 

[82] Moazzam, F., et al., *The leukocyte response to fluid stress.* Proc Natl Acad Sci U S A, 1997.

[83] Makino, A., et al., *Control of neutrophil pseudopods by fluid shear: role of Rho family GTPases.*

[84] Komai, Y. and G.W. Schmid-Schönbein, *De-activation of neutrophils in suspension by fluid shear stress: a requirement for erythrocytes.* Ann Biomed Eng, 2005. 33(10): p. 1375-86.

*of circulating leukocytes.* J Leukoc Biol, 2002. 72(1): p. 133-9.

Am J Physiol Cell Physiol, 2005. 288(4): p. C863-71.


[121] Haidekker, M.A., N. L'Heureux, and J.A. Frangos, *Fluid shear stress increases membrane fluidity in endothelial cells: a study with DCVJ fluorescence.* Am J Physiol Heart Circ Physiol, 2000. 278(4): p. H1401-6.

250 Lipoproteins – Role in Health and Diseases

[103] Fialkow, L., Y. Wang, and G.P. Downey, *Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function.* Free Radic Biol Med, 2007. 42(2): p. 153-64. [104] Guzik, T.J., R. Korbut, and T. Adamek-Guzik, *Nitric oxide and superoxide in inflammation* 

[105] Dal Secco, D., et al., *Nitric oxide inhibits neutrophil migration by a mechanism dependent on* 

[106] Kubes, P., M. Suzuki, and D.N. Granger, *Nitric oxide: an endogenous modulator of* 

[107] Kubes, P., et al., *Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide* 

[108] Gaboury, J., et al., *Nitric oxide prevents leukocyte adherence: role of superoxide.* Am J

[109] Vilhardt, F. and B. van Deurs, *The phagocyte NADPH oxidase depends on cholesterol-*

[110] Fukuda, S., et al., *Contribution of fluid shear response in leukocytes to hemodynamic* 

[111] Suzuki, H., et al., *Impaired leukocyte-endothelial cell interaction in spontaneously* 

[112] Arndt, H., C.W. Smith, and D.N. Granger, *Leukocyte-endothelial cell adhesion in spontaneously hypertensive and normotensive rats.* Hypertension, 1993. 21(5): p. 667-73. [113] Suematsu, M., et al., *The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis.* Microcirculation, 2002. 9(4): p.

[114] Kaul, S., R.C. Padgett, and D.D. Heistad, *Role of platelets and leukocytes in modulation of* 

[115] Mugge, A., et al., *Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo.*

[116] Faraci, F.M., et al., *Effect of atherosclerosis on cerebral vascular responses to activation of* 

[117] DeLano, F.A. and G.W. Schmid-Schönbein, *Enhancement of glucocorticoid and mineralocorticoid receptor density in the microcirculation of the spontaneously hypertensive rat.*

[118] Sutanto, W., et al., *Corticosteroid receptor plasticity in the central nervous system of various* 

[119] Fukuda, S., H. Mitsuoka, and G.W. Schmid-Schönbein, *Leukocyte fluid shear response in* 

[120] Sugihara-Seki, M. and G.W. Schmid-Schönbein, *The fluid shear stress distribution on the membrane of leukocytes in the microcirculation.* J Biomech Eng, 2003. 125(5): p. 628-38.

*enriched membrane microdomains for assembly.* EMBO J, 2004. 23(4): p. 739-48.

*resistance in the spontaneously hypertensive rat.* Circ Res, 2004. 95(1): p. 100-8.

*and immune regulation.* J Physiol Pharmacol, 2003. 54(4): p. 469-87.

*leukocyte adhesion.* Proc Natl Acad Sci U S A, 1991. 88(11): p. 4651-5.

*and mast cells.* Faseb J, 1993. 7(13): p. 1293-9.

*hypertensive rats.* Hypertension, 1994. 24(6): p. 719-27.

*vascular tone.* Ann N Y Acad Sci, 1994. 714: p. 122-35.

*leukocytes and platelets in monkeys.* Stroke, 1991. 22(6): p. 790-6.

*the presence of glucocorticoid.* J Leukoc Biol, 2004. 75(4): p. 664-70.

Atherosclerosis, 1992. 95(2-3): p. 211-22.

Microcirculation, 2004. 11(1): p. 69-78.

*rat models.* Endocr Regul, 1992. 26(3): p. 111-8.

Physiol, 1993. 265(3 Pt 2): p. H862-7.

259-76.

*ICAM-1: role of soluble guanylate cyclase.* Nitric Oxide, 2006. 15(1): p. 77-86.


**Management of Hyper and Dyslipoproteinemias** 

252 Lipoproteins – Role in Health and Diseases

[139] Johnson, B.D., et al., *Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored* 

*Women's Ischemia Syndrome Evaluation (WISE).* Circulation, 2004. 109(6): p. 726-32. [140] Tomida, K., et al., *Hypercholesterolemia induces leukocyte entrapment in the retinal* 

*microcirculation of rats.* Curr Eye Res, 2001. 23(1): p. 38-43.
